VersaVIT is a vitrectomy system for the retinal surgery market.
“The entry of VersaVIT into the global vitrectomy market is a major milestone in Synergetics’ strategy to enter into higher growth areas of retinal surgery,” said David Hable, president and CEO, in the release. “We believe that VersaVIT is a ‘game changer’ given its functionality, portability and competitive pricing relative to traditional vitrectomy systems.”
Synergetics USA is headquartered in O’Fallon, Mo.
Related Articles on FDA Clearances:
FDA Approves First Glaucoma Stent for Cataract Surgery
Cardinal Health Receives New FDA Clearance for Durablue Sterilization Wrap
InTouch Health Receives FDA 510(k) Clearance for Remote Presence Devices
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
